ResearcherInsermNo recent work listed
Dominique Lombardo
Matched on OpenAlex author ID A5100895027. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 4 papers · 2019: 1 paper
Papers 8
- Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fimmu.2019.03070↗
- Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2017.411↗
- Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. Co-author DOI 10.1080/2162402x.2018.1504727↗
- Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic … Co-author DOI 10.18632/oncotarget.23619↗
- Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.26310↗
- Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Co-author DOI 10.1038/ncomms16031↗
- Further characterization of HDAC and SIRT gene expression patterns in pancreatic cancer and their relation to disease outcome. Co-author DOI 10.1371/journal.pone.0108520↗
- Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer. Co-author DOI 10.4161/onci.1.1.18459↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Juan Iovanna · 5 shared papers, 2014–2019 · strength 0.33
- Paper Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocar… DOI 10.3389/fimmu.2019.03070↗
- Paper Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells. DOI 10.18632/oncotarget.26310↗
- Paper Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma. DOI 10.1038/bjc.2017.411↗
- Eric Mas · 5 shared papers, 2012–2019 · strength 0.32
- Paper Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester … DOI 10.18632/oncotarget.23619↗
- Paper Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocar… DOI 10.3389/fimmu.2019.03070↗
- Paper Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. DOI 10.1080/2162402x.2018.1504727↗
- Aurélie Collignon · 4 shared papers, 2012–2019 · strength 0.29
- Paper Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester … DOI 10.18632/oncotarget.23619↗
- Paper Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocar… DOI 10.3389/fimmu.2019.03070↗
- Paper Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. DOI 10.1080/2162402x.2018.1504727↗
- Carole Siret · 3 shared papers, 2018–2019 · strength 0.24
- Paper Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocar… DOI 10.3389/fimmu.2019.03070↗
- Paper Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells. DOI 10.18632/oncotarget.26310↗
- Paper Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma. DOI 10.1038/bjc.2017.411↗
- Evelyne Béraud · 3 shared papers, 2012–2018 · strength 0.20
- Paper Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester … DOI 10.18632/oncotarget.23619↗
- Paper Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. DOI 10.1080/2162402x.2018.1504727↗
- Paper Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic can… DOI 10.4161/onci.1.1.18459↗
- Richard Tomasini · 3 shared papers, 2017–2018 · strength 0.19
- Paper Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. DOI 10.1080/2162402x.2018.1504727↗
- Paper Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma. DOI 10.1038/bjc.2017.411↗
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Աննա Մարտիրոսյան · 2 shared papers, 2018–2019 · strength 0.15
- Aurélie Dobric · 2 shared papers, 2018 · strength 0.15
- Frederic André · 2 shared papers, 2018 · strength 0.14
- Françoise Boudouresque · 1 shared paper, 2018 · strength 0.09
- Yolande Berthois · 1 shared paper, 2018 · strength 0.09
- Philippe Soubeyran · 1 shared paper, 2018 · strength 0.09
- Jérémy Nigri · 1 shared paper, 2018 · strength 0.07
- Nelson Dusetti · 1 shared paper, 2018 · strength 0.07
- Véronique Secq · 1 shared paper, 2017 · strength 0.05
- Julie Roques · 1 shared paper, 2017 · strength 0.05
- Fabienne Guillaumond · 1 shared paper, 2017 · strength 0.05
- Tristan Gicquel · 1 shared paper, 2017 · strength 0.05
- Sophie Vasseur · 1 shared paper, 2017 · strength 0.05
- Victoire Gouirand · 1 shared paper, 2017 · strength 0.05
- Jared R. Mayers · 1 shared paper, 2017 · strength 0.05
- Orianne Olivares · 1 shared paper, 2017 · strength 0.05
- Matthew G. Vander Heiden · 1 shared paper, 2017 · strength 0.05
- Daniel Olive · 1 shared paper, 2012 · strength 0.04
- Céline Loncle · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.